The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines

<i>Background:</i> Approximately 10–20% of subjects vaccinated with HBsAg-based hepatitis B virus (HBV) vaccines are non-responders. BM32 is a recombinant grass pollen allergy vaccine containing the HBV-derived preS surface antigen as an immunological carrier protein. PreS includes the binding site...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Inna Tulaeva, Felix Lehmann, Nora Goldmann, Alexandra Dubovets, Daria Trifonova, Mikhail Tulaev, Carolin Cornelius, Milena Weber, Margarete Focke-Tejkl, Alexander Karaulov, Rainer Henning, David Niklas Springer, Ursula Wiedermann, Dieter Glebe, Rudolf Valenta
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2024-09-01
סדרה:	Vaccines
נושאים:	HBV vaccines preS surface protein HBsAg non-responsiveness
גישה מקוונת:	https://www.mdpi.com/2076-393X/12/10/1123
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!